Researchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibitors, a new class of anti-cancer drugs.

MENLO PARK, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.28 per share of common ...

Still, Labcorp, cut the top-end of its 2024 adjusted profit forecast to $14.70 per share from $14.90, due to an impact of ...

Bayesian Health CEO Suchi Saria is tackling sepsis and leveraging AI to enhance patient care, as highlighted in Business ...

Health data should be available for research. At the same time, a high level of data protection is essential to ensure ...

(Reuters) -Philip Morris, British American Tobacco, and Japan Tobacco will pay C$32.5 billion ($23.6 billion) to settle a ...

The Patriot Act is a prime example of how the liberties the US claims to grant Americans never really existed for some.

Geneva, Switzerland & Tokyo, Japan, Oct. 18, 2024 (GLOBE NEWSWIRE) -- ...